ビタミンB6原薬市場の2030年までの予測：タイプ、純度、用途、地域別の世界分析

Stratistics MRCによると、ビタミンB6原薬の世界市場は2023年に2億2,160万米ドルを占め、予測期間中にCAGR 9.0％で成長し2030年には4億510万米ドルに達する見込みです。

製薬業界では、ビタミンB6原薬（Active Pharmaceutical Ingredient）市場は、主に薬用目的の活性型ビタミンB6を製造、販売、流通する部門に関係します。水溶性ビタミンB6はピリドキシンとも呼ばれ、体内の代謝、神経伝達物質の合成、ヘモグロビンの生成に不可欠です。ビタミンB6原薬業界にとって、様々な健康問題に対処し、一般的な幸福感を高めることは重要な目標です。人体のいくつかの代謝プロセスに関与する重要な補酵素がビタミンB6であり、しばしばピリドキシンとして知られています。

Proactive healthの調査によると、米国の消費者の44％がパンデミックの間に栄養補助食品の購入を増やしました。米国食品医薬品局（FDA）によると、ビタミンB6（ピリドキシン）を含む食品サプリメントを使用しているのは、通常の人口の約28～36％です。

高まる健康意識

代謝プロセスや神経学的健康など、健康全般においてビタミンが果たす重要な役割に対する意識が高まるにつれ、医薬品有効成分としてのビタミンB6の需要が高まっています。重要な生理学的活動をサポートし、不足に対処するため、消費者はビタミンB6を強化した医薬品製剤や栄養補助食品を熱心に探しています。さらに、ビタミンB6原薬は、ビタミン欠乏と多くの健康問題や健康志向のライフスタイルとの関連性に対する消費者の意識が高まった結果、医薬品業界や栄養補助食品業界によって様々な製品に配合されるようになった。

発展途上地域での認知度の低さ

多くの発展途上国では、ビタミンB6補給の意義やその健康上の利点は広く理解されていないです。ビタミンB6原薬を含む医薬製剤の採用は、一般市民や医療専門家のこの問題に対する理解不足によって妨げられています。ビタミンB6が様々な生物学的機能をサポートし、栄養不足に対処する上で果たす役割に関する知識不足が、関連製品の市場に悪影響を及ぼしています。この知識不足に対処し、消費者や医療専門家がビタミンB6の補給について十分な情報を得た上で選択するために必要な情報を提供するためには、教育プログラムや啓発キャンペーンが極めて重要です。

高齢化率の上昇

世界の高齢化により、心血管疾患や神経疾患など、加齢に関連した健康上の懸念が増加しており、そのうちのいくつかはビタミンB6欠乏症の影響を受ける可能性があります。高齢者層では栄養素の十分な吸収が困難になることが多いため、ビタミンB6の補給は欠乏症の管理と一般的な健康増進に不可欠です。ビタミンB6原薬は、高齢者特有の健康要件に対応し、加齢に関連する疾患の管理と予防を支援する医薬製剤の重要な成分です。

世界経済の課題

医療への支出や消費者の購買力は、景気後退や先行き不透明な時期によって大きな影響を受ける可能性があります。特にビタミンB6原薬を含む医薬品や栄養補助食品に対する需要の減少は、可処分所得の低下に起因する可能性があります。困難な経済状況下では、個人や医療専門家は、基本的な健康ニーズに必要なサプリメントよりも、必要でないサプリメントを優先する可能性があります。製薬企業は研究開発プロジェクトのための資金調達に問題を抱える可能性があり、革新的な製品の開発・上市に支障をきたす可能性があります。

COVID-19の影響：

市場力学は、世界のサプライチェーンの混乱、渡航制限、消費者の優先順位の変化によって影響を受けた。健康志向の高まりにより、栄養補助食品市場はほぼ安定的に推移したが、医薬品セクターは流通と製造の面で困難に見舞われました。ロックダウンや物流の困難が原料供給に影響を及ぼし、工業プロセスの遅延を引き起こす可能性があった。さらに、パンデミックの間中、消費者の購買パターンは景気の不透明感から影響を受け、その結果、必需品以外の健康食品の購入にも影響が及びました。

予測期間中、カプセルセグメントが最大になると予想される

カプセルはビタミンB6原薬を包装する効果的な手段を提供し、正確な投与と毎日のサプリメントレジメンへの簡単な組み込みを保証するため、予測期間中、カプセル分野が市場で最大のシェアを占めました。カプセルの人気の理由は、飲み込みやすく、味に関する問題が少なく、中身のビタミンB6の安定性が高いことです。さらに、カプセル化された製剤が提供する利便性と正確な投与が認知されたことにより、消費者の嗜好が大幅に高まり、このセグメントの急拡大に寄与しています。この動向の利点を利用して、製薬会社や栄養補助食品会社はビタミンB6原薬を含む様々なカプセル製品を発売し、健康志向のサプリメント市場を満足させています。

予測期間中にCAGRが最も高くなると予想されるのは筋肉けいれん分野です。

筋肉関連の問題に対するビタミンの有効性が確立されていることから、筋肉けいれん分野は収益性の高い拡大が見込まれています。筋肉機能に影響を与えるために、ビタミンB6は神経伝達物質の産生とアミノ酸の代謝に不可欠です。筋肉のけいれんとビタミンB6不足の関連性が認識されるにつれ、こうした不快感を予防・緩和するために、ビタミンB6原薬を含む製剤を積極的に探すようになっています。さらに、この重要な物質の欠乏と頻繁に関連する筋肉痛に対応するため、的を絞った医薬品や栄養補助食品のソリューションが開発されています。

最もシェアが高い地域：

予防医療が重視され、健康に対する意識が高まっていることから、アジア太平洋が市場で最も大きな割合を占めると予想されます。ビタミンB6原薬含有製品は、人々が栄養素を補うことの重要性を認識するにつれて、飛躍的に高い割合で消費されています。さらに、ビタミンB6原薬で強化された医薬品製剤の需要は、消費者が全体的な健康を改善し、ビタミン欠乏症に対処する方法を積極的に探していることによって牽引されています。

CAGRが最も高い地域

アジア太平洋は収益性の高い成長が見込まれます。健康とウェルネスを促進する政府の施策や、可処分資金を持つ中間所得層の増加により、良好な市場環境が確立されています。医薬品の品質と安全性を保証する規制の枠組みによって消費者の信頼が強化され、この地域における市場の拡大をさらに後押ししています。さらに、アジア太平洋の栄養補助食品と医薬品部門は、新製品開発と技術革新への献身を証明しています。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます。

• 企業プロファイル
  • 追加市場参入企業の包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推定・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データ鉱業
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査情報源
  • 1次調査情報源
  • 2次調査情報源
  • 前提条件

第3章 市場動向分析

• イントロダクション
• 促進要因
• 抑制要因
• 機会
• 脅威
• 用途分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界のビタミンB6原薬市場：タイプ別

• イントロダクション
• カプセル
• クリーム
• 液体と注射
• シロップ
• タブレット
• その他のタイプ

第6章 世界のビタミンB6原薬市場：純度別

• イントロダクション
• 食品グレード
• 飼料グレード

第7章 世界のビタミンB6原薬市場：用途別

• イントロダクション
• 貧血
• 倦怠感
• 不眠症
• 更年期障害
• 筋肉けいれん
• 月経前症候群
• 保水力
• 製薬産業
• 飲食品業界
• 動物の栄養学
• その他の用途

第8章 世界のビタミンB6原薬市場：地域別

• イントロダクション
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他の欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他のアジア太平洋
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他の南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他の中東とアフリカ

第9章 主要発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第10章 企業プロファイル

• DSM Sinochem Pharmaceuticals
• Lonza Group Ltd
• Hegno Pharmaceutical Co., Ltd
• BASF SE
• Dishman Carbogen Amcis Ltd
• Zhejiang NHU Co., Ltd
• Jiangxi Tianxin Pharmaceutical Co., Ltd
• Huazhong Pharmaceutical Co., Ltd
• Tianjin Zhongrui Pharmaceutical Co., Ltd
• Anhui Sunhere Pharmaceutical Excipients Co., Ltd
• Anhui Tiger Biotech Co., Ltd
• Taizhou Tianrui Chemical Co., Ltd
• Hubei Gedian Humanwell Pharmaceutical Co., Ltd

List of Tables

• Table 1 Global Vitamin B6 API Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Vitamin B6 API Market Outlook, By Type (2021-2030) ($MN)
• Table 3 Global Vitamin B6 API Market Outlook, By Capsules (2021-2030) ($MN)
• Table 4 Global Vitamin B6 API Market Outlook, By Cream (2021-2030) ($MN)
• Table 5 Global Vitamin B6 API Market Outlook, By Liquid and Injection (2021-2030) ($MN)
• Table 6 Global Vitamin B6 API Market Outlook, By Syrup (2021-2030) ($MN)
• Table 7 Global Vitamin B6 API Market Outlook, By Tablets (2021-2030) ($MN)
• Table 8 Global Vitamin B6 API Market Outlook, By Other Types (2021-2030) ($MN)
• Table 9 Global Vitamin B6 API Market Outlook, By Purity (2021-2030) ($MN)
• Table 10 Global Vitamin B6 API Market Outlook, By Food Grade (2021-2030) ($MN)
• Table 11 Global Vitamin B6 API Market Outlook, By Feed Grade (2021-2030) ($MN)
• Table 12 Global Vitamin B6 API Market Outlook, By Application (2021-2030) ($MN)
• Table 13 Global Vitamin B6 API Market Outlook, By Anaemia (2021-2030) ($MN)
• Table 14 Global Vitamin B6 API Market Outlook, By Fatigue (2021-2030) ($MN)
• Table 15 Global Vitamin B6 API Market Outlook, By Insomnia (2021-2030) ($MN)
• Table 16 Global Vitamin B6 API Market Outlook, By Menopausal Depression (2021-2030) ($MN)
• Table 17 Global Vitamin B6 API Market Outlook, By Muscular Cramps (2021-2030) ($MN)
• Table 18 Global Vitamin B6 API Market Outlook, By Premenstrual Syndrome (2021-2030) ($MN)
• Table 19 Global Vitamin B6 API Market Outlook, By Water Retention (2021-2030) ($MN)
• Table 20 Global Vitamin B6 API Market Outlook, By Pharmaceutical Industry (2021-2030) ($MN)
• Table 21 Global Vitamin B6 API Market Outlook, By Food & Beverage Industry (2021-2030) ($MN)
• Table 22 Global Vitamin B6 API Market Outlook, By Animal Nutrition (2021-2030) ($MN)
• Table 23 Global Vitamin B6 API Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 24 North America Vitamin B6 API Market Outlook, By Country (2021-2030) ($MN)
• Table 25 North America Vitamin B6 API Market Outlook, By Type (2021-2030) ($MN)
• Table 26 North America Vitamin B6 API Market Outlook, By Capsules (2021-2030) ($MN)
• Table 27 North America Vitamin B6 API Market Outlook, By Cream (2021-2030) ($MN)
• Table 28 North America Vitamin B6 API Market Outlook, By Liquid and Injection (2021-2030) ($MN)
• Table 29 North America Vitamin B6 API Market Outlook, By Syrup (2021-2030) ($MN)
• Table 30 North America Vitamin B6 API Market Outlook, By Tablets (2021-2030) ($MN)
• Table 31 North America Vitamin B6 API Market Outlook, By Other Types (2021-2030) ($MN)
• Table 32 North America Vitamin B6 API Market Outlook, By Purity (2021-2030) ($MN)
• Table 33 North America Vitamin B6 API Market Outlook, By Food Grade (2021-2030) ($MN)
• Table 34 North America Vitamin B6 API Market Outlook, By Feed Grade (2021-2030) ($MN)
• Table 35 North America Vitamin B6 API Market Outlook, By Application (2021-2030) ($MN)
• Table 36 North America Vitamin B6 API Market Outlook, By Anaemia (2021-2030) ($MN)
• Table 37 North America Vitamin B6 API Market Outlook, By Fatigue (2021-2030) ($MN)
• Table 38 North America Vitamin B6 API Market Outlook, By Insomnia (2021-2030) ($MN)
• Table 39 North America Vitamin B6 API Market Outlook, By Menopausal Depression (2021-2030) ($MN)
• Table 40 North America Vitamin B6 API Market Outlook, By Muscular Cramps (2021-2030) ($MN)
• Table 41 North America Vitamin B6 API Market Outlook, By Premenstrual Syndrome (2021-2030) ($MN)
• Table 42 North America Vitamin B6 API Market Outlook, By Water Retention (2021-2030) ($MN)
• Table 43 North America Vitamin B6 API Market Outlook, By Pharmaceutical Industry (2021-2030) ($MN)
• Table 44 North America Vitamin B6 API Market Outlook, By Food & Beverage Industry (2021-2030) ($MN)
• Table 45 North America Vitamin B6 API Market Outlook, By Animal Nutrition (2021-2030) ($MN)
• Table 46 North America Vitamin B6 API Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 47 Europe Vitamin B6 API Market Outlook, By Country (2021-2030) ($MN)
• Table 48 Europe Vitamin B6 API Market Outlook, By Type (2021-2030) ($MN)
• Table 49 Europe Vitamin B6 API Market Outlook, By Capsules (2021-2030) ($MN)
• Table 50 Europe Vitamin B6 API Market Outlook, By Cream (2021-2030) ($MN)
• Table 51 Europe Vitamin B6 API Market Outlook, By Liquid and Injection (2021-2030) ($MN)
• Table 52 Europe Vitamin B6 API Market Outlook, By Syrup (2021-2030) ($MN)
• Table 53 Europe Vitamin B6 API Market Outlook, By Tablets (2021-2030) ($MN)
• Table 54 Europe Vitamin B6 API Market Outlook, By Other Types (2021-2030) ($MN)
• Table 55 Europe Vitamin B6 API Market Outlook, By Purity (2021-2030) ($MN)
• Table 56 Europe Vitamin B6 API Market Outlook, By Food Grade (2021-2030) ($MN)
• Table 57 Europe Vitamin B6 API Market Outlook, By Feed Grade (2021-2030) ($MN)
• Table 58 Europe Vitamin B6 API Market Outlook, By Application (2021-2030) ($MN)
• Table 59 Europe Vitamin B6 API Market Outlook, By Anaemia (2021-2030) ($MN)
• Table 60 Europe Vitamin B6 API Market Outlook, By Fatigue (2021-2030) ($MN)
• Table 61 Europe Vitamin B6 API Market Outlook, By Insomnia (2021-2030) ($MN)
• Table 62 Europe Vitamin B6 API Market Outlook, By Menopausal Depression (2021-2030) ($MN)
• Table 63 Europe Vitamin B6 API Market Outlook, By Muscular Cramps (2021-2030) ($MN)
• Table 64 Europe Vitamin B6 API Market Outlook, By Premenstrual Syndrome (2021-2030) ($MN)
• Table 65 Europe Vitamin B6 API Market Outlook, By Water Retention (2021-2030) ($MN)
• Table 66 Europe Vitamin B6 API Market Outlook, By Pharmaceutical Industry (2021-2030) ($MN)
• Table 67 Europe Vitamin B6 API Market Outlook, By Food & Beverage Industry (2021-2030) ($MN)
• Table 68 Europe Vitamin B6 API Market Outlook, By Animal Nutrition (2021-2030) ($MN)
• Table 69 Europe Vitamin B6 API Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 70 Asia Pacific Vitamin B6 API Market Outlook, By Country (2021-2030) ($MN)
• Table 71 Asia Pacific Vitamin B6 API Market Outlook, By Type (2021-2030) ($MN)
• Table 72 Asia Pacific Vitamin B6 API Market Outlook, By Capsules (2021-2030) ($MN)
• Table 73 Asia Pacific Vitamin B6 API Market Outlook, By Cream (2021-2030) ($MN)
• Table 74 Asia Pacific Vitamin B6 API Market Outlook, By Liquid and Injection (2021-2030) ($MN)
• Table 75 Asia Pacific Vitamin B6 API Market Outlook, By Syrup (2021-2030) ($MN)
• Table 76 Asia Pacific Vitamin B6 API Market Outlook, By Tablets (2021-2030) ($MN)
• Table 77 Asia Pacific Vitamin B6 API Market Outlook, By Other Types (2021-2030) ($MN)
• Table 78 Asia Pacific Vitamin B6 API Market Outlook, By Purity (2021-2030) ($MN)
• Table 79 Asia Pacific Vitamin B6 API Market Outlook, By Food Grade (2021-2030) ($MN)
• Table 80 Asia Pacific Vitamin B6 API Market Outlook, By Feed Grade (2021-2030) ($MN)
• Table 81 Asia Pacific Vitamin B6 API Market Outlook, By Application (2021-2030) ($MN)
• Table 82 Asia Pacific Vitamin B6 API Market Outlook, By Anaemia (2021-2030) ($MN)
• Table 83 Asia Pacific Vitamin B6 API Market Outlook, By Fatigue (2021-2030) ($MN)
• Table 84 Asia Pacific Vitamin B6 API Market Outlook, By Insomnia (2021-2030) ($MN)
• Table 85 Asia Pacific Vitamin B6 API Market Outlook, By Menopausal Depression (2021-2030) ($MN)
• Table 86 Asia Pacific Vitamin B6 API Market Outlook, By Muscular Cramps (2021-2030) ($MN)
• Table 87 Asia Pacific Vitamin B6 API Market Outlook, By Premenstrual Syndrome (2021-2030) ($MN)
• Table 88 Asia Pacific Vitamin B6 API Market Outlook, By Water Retention (2021-2030) ($MN)
• Table 89 Asia Pacific Vitamin B6 API Market Outlook, By Pharmaceutical Industry (2021-2030) ($MN)
• Table 90 Asia Pacific Vitamin B6 API Market Outlook, By Food & Beverage Industry (2021-2030) ($MN)
• Table 91 Asia Pacific Vitamin B6 API Market Outlook, By Animal Nutrition (2021-2030) ($MN)
• Table 92 Asia Pacific Vitamin B6 API Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 93 South America Vitamin B6 API Market Outlook, By Country (2021-2030) ($MN)
• Table 94 South America Vitamin B6 API Market Outlook, By Type (2021-2030) ($MN)
• Table 95 South America Vitamin B6 API Market Outlook, By Capsules (2021-2030) ($MN)
• Table 96 South America Vitamin B6 API Market Outlook, By Cream (2021-2030) ($MN)
• Table 97 South America Vitamin B6 API Market Outlook, By Liquid and Injection (2021-2030) ($MN)
• Table 98 South America Vitamin B6 API Market Outlook, By Syrup (2021-2030) ($MN)
• Table 99 South America Vitamin B6 API Market Outlook, By Tablets (2021-2030) ($MN)
• Table 100 South America Vitamin B6 API Market Outlook, By Other Types (2021-2030) ($MN)
• Table 101 South America Vitamin B6 API Market Outlook, By Purity (2021-2030) ($MN)
• Table 102 South America Vitamin B6 API Market Outlook, By Food Grade (2021-2030) ($MN)
• Table 103 South America Vitamin B6 API Market Outlook, By Feed Grade (2021-2030) ($MN)
• Table 104 South America Vitamin B6 API Market Outlook, By Application (2021-2030) ($MN)
• Table 105 South America Vitamin B6 API Market Outlook, By Anaemia (2021-2030) ($MN)
• Table 106 South America Vitamin B6 API Market Outlook, By Fatigue (2021-2030) ($MN)
• Table 107 South America Vitamin B6 API Market Outlook, By Insomnia (2021-2030) ($MN)
• Table 108 South America Vitamin B6 API Market Outlook, By Menopausal Depression (2021-2030) ($MN)
• Table 109 South America Vitamin B6 API Market Outlook, By Muscular Cramps (2021-2030) ($MN)
• Table 110 South America Vitamin B6 API Market Outlook, By Premenstrual Syndrome (2021-2030) ($MN)
• Table 111 South America Vitamin B6 API Market Outlook, By Water Retention (2021-2030) ($MN)
• Table 112 South America Vitamin B6 API Market Outlook, By Pharmaceutical Industry (2021-2030) ($MN)
• Table 113 South America Vitamin B6 API Market Outlook, By Food & Beverage Industry (2021-2030) ($MN)
• Table 114 South America Vitamin B6 API Market Outlook, By Animal Nutrition (2021-2030) ($MN)
• Table 115 South America Vitamin B6 API Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 116 Middle East & Africa Vitamin B6 API Market Outlook, By Country (2021-2030) ($MN)
• Table 117 Middle East & Africa Vitamin B6 API Market Outlook, By Type (2021-2030) ($MN)
• Table 118 Middle East & Africa Vitamin B6 API Market Outlook, By Capsules (2021-2030) ($MN)
• Table 119 Middle East & Africa Vitamin B6 API Market Outlook, By Cream (2021-2030) ($MN)
• Table 120 Middle East & Africa Vitamin B6 API Market Outlook, By Liquid and Injection (2021-2030) ($MN)
• Table 121 Middle East & Africa Vitamin B6 API Market Outlook, By Syrup (2021-2030) ($MN)
• Table 122 Middle East & Africa Vitamin B6 API Market Outlook, By Tablets (2021-2030) ($MN)
• Table 123 Middle East & Africa Vitamin B6 API Market Outlook, By Other Types (2021-2030) ($MN)
• Table 124 Middle East & Africa Vitamin B6 API Market Outlook, By Purity (2021-2030) ($MN)
• Table 125 Middle East & Africa Vitamin B6 API Market Outlook, By Food Grade (2021-2030) ($MN)
• Table 126 Middle East & Africa Vitamin B6 API Market Outlook, By Feed Grade (2021-2030) ($MN)
• Table 127 Middle East & Africa Vitamin B6 API Market Outlook, By Application (2021-2030) ($MN)
• Table 128 Middle East & Africa Vitamin B6 API Market Outlook, By Anaemia (2021-2030) ($MN)
• Table 129 Middle East & Africa Vitamin B6 API Market Outlook, By Fatigue (2021-2030) ($MN)
• Table 130 Middle East & Africa Vitamin B6 API Market Outlook, By Insomnia (2021-2030) ($MN)
• Table 131 Middle East & Africa Vitamin B6 API Market Outlook, By Menopausal Depression (2021-2030) ($MN)
• Table 132 Middle East & Africa Vitamin B6 API Market Outlook, By Muscular Cramps (2021-2030) ($MN)
• Table 133 Middle East & Africa Vitamin B6 API Market Outlook, By Premenstrual Syndrome (2021-2030) ($MN)
• Table 134 Middle East & Africa Vitamin B6 API Market Outlook, By Water Retention (2021-2030) ($MN)
• Table 135 Middle East & Africa Vitamin B6 API Market Outlook, By Pharmaceutical Industry (2021-2030) ($MN)
• Table 136 Middle East & Africa Vitamin B6 API Market Outlook, By Food & Beverage Industry (2021-2030) ($MN)
• Table 137 Middle East & Africa Vitamin B6 API Market Outlook, By Animal Nutrition (2021-2030) ($MN)
• Table 138 Middle East & Africa Vitamin B6 API Market Outlook, By Other Applications (2021-2030) ($MN)

According to Stratistics MRC, the Global Vitamin B6 API Market is accounted for $221.6 million in 2023 and is expected to reach $405.1 million by 2030 growing at a CAGR of 9.0% during the forecast period. In the pharmaceutical industry, the market for Vitamin B6 API (Active Pharmaceutical Ingredient) pertains to the division that manufactures, sells, and distributes the active form of Vitamin B6, mostly for medicinal purposes. The water-soluble vitamin B6, also referred to as pyridoxine, is crucial for the body's metabolism, the synthesis of neurotransmitters, and the production of hemoglobin. Addressing a variety of health issues and enhancing general well-being are important objectives for the vitamin B6 API industry. A vital coenzyme involved in several metabolic processes in the human body is vitamin B6, often known as pyridoxine.

According to a survey by Proactive health, 44% of US consumers have increased purchases of dietary supplements during the pandemic. According to the U.S. Food and Drug Administration (FDA), about 28-36% of the normal population uses food supplements that contain vitamin B6 (pyridoxine).

Market Dynamics:

Driver:

Increasing health awareness

The demand for Vitamin B6 as an active pharmaceutical ingredient has increased as individuals become increasingly conscious of the critical role vitamins play in overall well-being, including metabolic processes and neurological health. In order to support vital physiological activities and handle inadequacies, consumers are diligently looking for pharmaceutical formulations and nutritional supplements enhanced with vitamin B6. Additionally, vitamin B6 API has been included in a variety of products by the pharmaceutical and nutraceutical industries as a result of growing consumer awareness of the connection between vitamin deficiencies and a number of health issues and health-conscious lifestyles.

Restraint:

Limited awareness in developing regions

The significance of vitamin B6 supplementation and its possible health benefits are not widely understood in many underdeveloped nations. The adoption of pharmaceutical formulations containing Vitamin B6 API is hampered by the general public's and healthcare professionals' lack of understanding of this issue. The market for related products is negatively impacted by a lack of knowledge on the role that vitamin B6 performs in supporting different biological functions and addressing nutritional deficits. To address this knowledge gap and provide consumers and healthcare professionals with the information they need to make informed choices about vitamin B6 supplementation, educational programs and awareness campaigns are crucial.

Opportunity:

Rising aging population

An aging population around the world has contributed to a rise in age-related health concerns, including cardiovascular disease and neurological diseases, several of which can be impacted by vitamin B6 deficiency. Supplementing with Vitamin B6 is essential for managing deficiencies and promoting general health because the senior population frequently experiences difficulties with adequate nutrient absorption. Vitamin B6 API is a crucial component of pharmaceutical formulations that address the unique health requirements of the elderly population and aid in the management and prevention of age-related illnesses.

Threat:

Global economic challenges

Spending on healthcare and consumer purchasing power can be severely impacted by economic downturns and periods of uncertainty. A decrease in the demand for medications and nutritional supplements, particularly those containing vitamin B6 API, may result from lower disposable income. In difficult financial times, individuals and healthcare professionals might give priority to non-essential supplements over those that are necessary for basic health needs. Pharmaceutical businesses might have problems obtaining funding for R&D projects, which could hinder their ability to innovate and launch innovative products.

COVID-19 Impact:

The market dynamics were impacted by disruptions in global supply chains, travel restrictions, and changes in consumer priorities. Due to growing health consciousness, the market for nutritional supplements remained mostly stable, but the pharmaceutical sector experienced difficulties with distribution and manufacture. Lockdowns and logistical difficulties impacted raw material supply, which could cause industrial processes to be delayed. Furthermore, throughout the pandemic, consumer buying patterns were impacted by economic uncertainty, which in turn affected the purchase of non-essential health products.

The capsules segment is expected to be the largest during the forecast period

Because capsules offer an effective means to package vitamin B6 API, ensuring precise dosing and simple incorporation into daily supplement regimens, the capsules sector held the largest share of the market over the projected period. The reason for the popularity of capsules is that they are easier to swallow, have fewer taste-related problems, and have better stability for the vitamin B6 that is inside. Moreover, due to the perceived convenience and accurate dosing that encapsulated formulations provide, consumer preferences have increased substantially, which has contributed to the segment's rapid expansion. Utilizing the benefit of this trend, pharmaceutical and nutraceutical businesses are launching a range of capsule products containing Vitamin B6 API to satisfy the market for wellness-focused supplements.

The muscular cramps segment is expected to have the highest CAGR during the forecast period

The muscle cramps area is anticipated to have profitable expansion due to the vitamin's established effectiveness in treating muscle-related problems. In order to affect muscular function, vitamin B6 is essential for the production of neurotransmitters and the metabolism of amino acids. As individuals become more aware of the connection between muscle cramps and vitamin B6 insufficiency, they are actively searching for formulations that contain vitamin B6 API in order to prevent and relieve these types of discomfort. Additionally, targeted pharmaceutical and nutraceutical solutions have been developed in response to muscle cramps, which are frequently associated with deficits in this vital substance.

Region with largest share:

Because of the increased emphasis on preventive healthcare and the development of health awareness, the Asia-Pacific region is expected to hold the largest proportion of the market. Vitamin B6 API-containing products are being consumed at an exponentially higher rate as people realize the significance of supplementing with nutrients. Additionally, demand for pharmaceutical formulations enhanced with Vitamin B6 API is being driven by consumers actively looking for ways to improve overall well-being and address vitamin deficiencies.

Region with highest CAGR:

Asia Pacific region is expected to hold profitable growth. A favorable market environment has been established by government measures that promote health and wellness as well as by the growing middle-class population with disposable funding. Consumer confidence has been bolstered by regulatory frameworks guaranteeing the quality and safety of pharmaceuticals, which has further propelled the market's expansion in the area. In addition, the Asia-Pacific region's nutraceutical and pharmaceutical sectors have proven their dedication to new product development and innovation.

Key players in the market:

Some of the key players in Vitamin B6 API market include DSM Sinochem Pharmaceuticals, Lonza Group Ltd, Hegno Pharmaceutical Co., Ltd, BASF SE, Dishman Carbogen Amcis Ltd, Zhejiang NHU Co., Ltd, Jiangxi Tianxin Pharmaceutical Co., Ltd, Huazhong Pharmaceutical Co., Ltd, Tianjin Zhongrui Pharmaceutical Co., Ltd, Anhui Sunhere Pharmaceutical Excipients Co., Ltd, Anhui Tiger Biotech Co., Ltd, Taizhou Tianrui Chemical Co., Ltd and Hubei Gedian Humanwell Pharmaceutical Co., Ltd.

Key Developments:

In November 2023, BASF increases defoamer capacity at its Dilovasi plant in Turkey. New production line set up to meet growing demand for Foamaster® and Foamstar® products in South-East Europe, the Middle East and Africa. BASF will improve its service to customers in the region and reduce lead times to ensure faster delivery.

In November 2023, BASF receives funding approval for electrolysis plant. With the approval of funding from the German Federal Ministry for Economic Affairs and Climate Action and the State of Rhineland-Palatinate, BASF has taken a major step closer in building a PEM electrolyser for its project aimed at decarbonising the chemical industry.

Types Covered:

• Capsules
• Cream
• Liquid and Injection
• Syrup
• Tablets
• Other Types

Purities Covered:

• Food Grade
• Feed Grade

Applications Covered:

• Anaemia
• Fatigue
• Insomnia
• Menopausal Depression
• Muscular Cramps
• Premenstrual Syndrome
• Water Retention
• Pharmaceutical Industry
• Food & Beverage Industry
• Animal Nutrition
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Vitamin B6 API Market, By Type

• 5.1 Introduction
• 5.2 Capsules
• 5.3 Cream
• 5.4 Liquid and Injection
• 5.5 Syrup
• 5.6 Tablets
• 5.7 Other Types

6 Global Vitamin B6 API Market, By Purity

• 6.1 Introduction
• 6.2 Food Grade
• 6.3 Feed Grade

7 Global Vitamin B6 API Market, By Application

• 7.1 Introduction
• 7.2 Anaemia
• 7.3 Fatigue
• 7.4 Insomnia
• 7.5 Menopausal Depression
• 7.6 Muscular Cramps
• 7.7 Premenstrual Syndrome
• 7.8 Water Retention
• 7.9 Pharmaceutical Industry
• 7.10 Food & Beverage Industry
• 7.11 Animal Nutrition
• 7.12 Other Applications

8 Global Vitamin B6 API Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 DSM Sinochem Pharmaceuticals
• 10.2 Lonza Group Ltd
• 10.3 Hegno Pharmaceutical Co., Ltd
• 10.4 BASF SE
• 10.5 Dishman Carbogen Amcis Ltd
• 10.6 Zhejiang NHU Co., Ltd
• 10.7 Jiangxi Tianxin Pharmaceutical Co., Ltd
• 10.8 Huazhong Pharmaceutical Co., Ltd
• 10.9 Tianjin Zhongrui Pharmaceutical Co., Ltd
• 10.10 Anhui Sunhere Pharmaceutical Excipients Co., Ltd
• 10.11 Anhui Tiger Biotech Co., Ltd
• 10.12 Taizhou Tianrui Chemical Co., Ltd
• 10.13 Hubei Gedian Humanwell Pharmaceutical Co., Ltd